4//SEC Filing
Lynch Samuel Eugene 4
Accession 0001209191-12-020640
CIK 0001138400other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 5:44 PM ET
Size
12.4 KB
Accession
0001209191-12-020640
Insider Transaction Report
Form 4
Lynch Samuel Eugene
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2012-03-30$2.40/sh+20,000$48,000→ 1,239,391 total - Purchase
Common Stock
2012-03-29$2.38/sh+30,638$72,891→ 1,200,029 total - Purchase
Common Stock
2012-03-30$2.46/sh+19,362$47,632→ 1,219,391 total
Holdings
- 5,550(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $2.33 and $2.40. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.
- [F2]This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $2.42 and $2.49. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.
- [F3]Dr. Lynch disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.
Issuer
BIOMIMETIC THERAPEUTICS, INC.
CIK 0001138400
Entity typeother
Related Parties
1- filerCIK 0001362148
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 5:44 PM ET
- Size
- 12.4 KB